B-hPD-1 plus/hPD-L1/hEGFR mice
| Strain Name | C57BL/6-Pdcd1tm3(PDCD1)Bcgen Cd274tm1(CD274)Bcgen Egfrtm2(EGFR)Bcgen/Bcgen | Common Name | B-hPD-1 plus/hPD-L1/hEGFR mice |
| Background | C57BL/6 | Catalog number | 113031 |
|
Related Genes |
PD-1, CD279, hPD-l, hSLE1, PDCD1, SLEB2, PD1, hPD-1, CD274, PDL1, B7-H, B7H1, PDCD1LG1, PD-L1, PDCD1L1, hPD-L1, ERBB, HER1, mENA, ERBB1, PIG61, NISBD2
|
||
|
NCBI Gene ID |
18566, 60533, 13649 | ||
Description
- PD-1 is a cell surface receptor belonging to the immunoglobulin superfamily. PD-1 is expressed on activated T cells, B cells, and myeloid cells. Its main function is to regulate the immune response and prevent excessive immune activation. When PD-1 binds to its ligands (PD-L1 and PD-L2), it sends inhibitory signals to T cells, dampening their activity.
- PD-L1 is a ligand for PD-1, mainly expressed on tumor cells, antigen-presenting cells, and some non-immune cells. By binding to PD-1 on T cells, PD-L1 can suppress the anti-tumor immune response, allowing tumor cells to evade immune surveillance.
- EGFR is a transmembrane protein with tyrosine kinase activity. EGFR is widely expressed on the surface of epithelial cells. Activation of EGFR by its ligands (such as EGF and TGF-α) initiates a series of intracellular signaling cascades that promote cell growth, proliferation, survival, and migration. Overexpression or mutation of EGFR is often associated with the development and progression of various cancers.
- The humanized mice provide valuable pre-clinical models for the development of drugs targeting PD-1, PD-L1, and EGFR. They can be used to evaluate the efficacy, safety, and pharmacokinetics of new drugs in a more relevant biological context.
Gene targeting strategy for B-hPD-1 plus/hPD-L1/hEGFR mice.
Human PD-1 gene encoding the extracellular region and mouse Pd-1 gene encoding the transmembrane and cytoplasmic region were inserted after the initiation codon ATG of mouse Pd-1 gene in B-hPD-1 plus/hPD-L1/hEGFR mice.
The exon 3 of mouse Pdl1 gene that encodes the IgV domain was replaced by human PD-L1 exon 3 in B-hPD-1 plus/hPD-L1/hEGFR mice.
The exons 2-17 of mouse Egfr gene that encode extracellular domain were replaced by human counterparts in B-hPD-1 plus/hPD-L1/hEGFR mice. The genomic region of mouse Egfr gene that encodes transmembrane domain and cytoplasmic portion was retained. The promoter, 5’UTR, signal peptide and 3’UTR region of the mouse gene were also retained. The chimeric EGFR expression was driven by endogenous mouse Egfr promoter, while mouse Egfr gene transcription and translation will be disrupted.
Strain specific analysis of EGFR, PD-1 and PD-L1 mRNA expression in wild-type C57BL/6 mice and B-hPD-1 plus/hPD-L1/hEGFR mice by RT-PCR. Spleen and heart RNA were isolated from wild-type C57BL/6 mice (+/+) and homozygous B-hPD-1 plus/hPD-L1/hEGFR mice (H/H;H/H;H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human EGFR, PD-1 and PD-L1 primers. Mouse Egfr, Pd-1 and Pd-l1 mRNA were detectable only in wild-type C57BL/6 mice. Human EGFR, PD-1 and PD-L1 mRNA were detectable only in homozygous B-hPD-1 plus/hPD-L1/hEGFR mice but not in wild-type mice.
Strain specific PD-1 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hPD-1 plus/hPD-L1/hEGFR mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hPD-1 plus/hPD-L1/hEGFR mice (H/H;H/H;H/H) stimulated with anti-mouse CD3ε antibody (7.5 μg, i.p.) in vivo for 24 hrs. Protein expression was analyzed with anti-mouse PD-1 antibody (Biolegend, 109104) and anti-human PD-1 antibody (Biolegend, 329904) by flow cytometry. Mouse PD-1 was only detectable in wild-type C57BL/6 mice. Human PD-1 was exclusively detectable in homozygous B-hPD-1 plus/hPD-L1/hEGFR mice, but not in wild-type C57BL/6 mice.
Strain specific PD-L1 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hPD-1 plus/hPD-L1/hEGFR mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hPD-1 plus/hPD-L1/hEGFR mice (H/H;H/H;H/H) stimulated with anti-mouse CD3ε antibody (7.5 μg, i.p.) in vivo for 24 hrs. Protein expression was analyzed with anti-mouse PD-L1 antibody (Biolegend, 124312) and anti-human PD-L1 antibody (Biolegend, 329706) by flow cytometry. Mouse PD-L1 was only detectable in wild-type C57BL/6 mice. Human PD-L1 was exclusively detectable in homozygous B-hPD-1 plus/hPD-L1/hEGFR mice, but not in wild-type C57BL/6 mice.
Immunohistochemical (IHC) analysis of EGFR expression in homozygous B-hPD-1 plus/hPD-L1/hEGFR mice. The liver and kidney were collected from WT and homozygous B-hPD-1 plus/hPD-L1/hEGFR mice (H/H;H/H;H/H), analyzed by IHC with anti-EGFR antibody. Mouse EGFR was detectable in WT mice, and human EGFR was detectable in homozygous B-hPD-1 plus/hPD-L1/hEGFR mice. The arrow indicates tissue cells with positive EGFR staining (brown).
+86-010-56967680
010-56967601
ir@bbctg.com.cn
Copyright © 2024 Biocytogen. All Rights Reserved
Powered by Fractal-technology